Literature DB >> 20151175

Early CNS relapse in a good-risk primary mediastinal large B-cell lymphoma after combined chemo- and radio-therapy.

Makoto Sasaki, Koichi Sugimoto, Azuchi Masuda, Yutaka Tsukune, Yuriko Yahata, Norio Komatsu.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20151175     DOI： 10.1007/s11060-010-0132-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  10 in total

1.  CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission.

Authors:  Vittorio Stefoni; Alessandro Broccoli; Cinzia Pellegrini; Enrico Derenzini; Mariapaola Fina; Pier Luigi Zinzani
Journal:  J Neurooncol       Date:  2009-04-18       Impact factor: 4.130

Review 2.  Central nervous system-directed preventative therapy in adults with lymphoma.

Authors:  Andrew McMillan
Journal:  Br J Haematol       Date:  2005-10       Impact factor: 6.998

Review 3.  CNS prophylaxis in lymphoma: who to target and what therapy to use.

Authors:  Quentin A Hill; Roger G Owen
Journal:  Blood Rev       Date:  2006-08-01       Impact factor: 8.250

Review 4.  CNS involvement in primary mediastinal large B-cell lymphoma.

Authors:  P C Bishop; W H Wilson; D Pearson; J Janik; E S Jaffe; P C Elwood
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

5.  Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.

Authors:  G Todeschini; A Ambrosetti; V Meneghini; G Pizzolo; F Menestrina; M Chilosi; F Benedetti; D Veneri; G L Cetto; G Perona
Journal:  J Clin Oncol       Date:  1990-05       Impact factor: 44.544

6.  Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.

Authors:  Naoto Tomita; Fumio Kodama; Heiwa Kanamori; Shigeki Motomura; Yoshiaki Ishigatsubo
Journal:  Cancer       Date:  2002-08-01       Impact factor: 6.860

Review 7.  Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.

Authors:  Koen van Besien; Christian Gisselbrecht; Michael Pfreundschuh; Emanuele Zucca
Journal:  Leuk Lymphoma       Date:  2008

8.  Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients.

Authors:  D Kirn; P Mauch; K Shaffer; G Pinkus; M A Shipp; W D Kaplan; N Tung; C Wheeler; C J Beard; G P Canellos
Journal:  J Clin Oncol       Date:  1993-07       Impact factor: 44.544

9.  Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

Authors:  Pier Luigi Zinzani; Maurizio Martelli; Venerino Poletti; Umberto Vitolo; Paolo G Gobbi; Tommaso Chisesi; Giovanni Barosi; Andrés J M Ferreri; Monia Marchetti; Nicola Pimpinelli; Sante Tura
Journal:  Haematologica       Date:  2008-07-04       Impact factor: 9.941

10.  Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.

Authors:  M Lazzarino; E Orlandi; M Paulli; E Boveri; E Morra; E Brusamolino; S Kindl; R Rosso; C Astori; M C Buonanno
Journal:  J Clin Oncol       Date:  1993-12       Impact factor: 44.544
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.